Nephrostomy Device Market Size

Global Nephrostomy Device Market size was valued at USD 1.3 billion in 2023 and is poised to grow from USD 1.41 billion in 2024 to USD 2.73 billion by 2032, growing at a CAGR of 8.6% during the forecast period (2025-2032). 

The nephrostomy devices market is being driven by various factors such as the growing prevalence of kidney stone disorder, a rising demand for minimally invasive surgical procedures, and increased awareness about these devices.

According to a study published in the National Center for Biotechnology Information (NCBI), urolithiasis affects approximately 12% of the global population. Additionally, the American Cancer Society predicts that there will be around 81,800 new cases of kidney cancer in the United States in 2023, further highlighting the high prevalence of kidney diseases.

The increasing incidence of kidney diseases, including cancer, creates a greater demand for nephrostomy devices. Individuals with cancer may require a nephrostomy if there is a blockage in their urinary system. This drives the market growth as the need for these devices increases. The demand for minimally invasive surgeries (MIS) is another significant factor contributing to the market's growth.

Compared to open surgery, minimally invasive surgery offers numerous advantages, such as shorter hospital stays, reduced blood loss, lower postoperative complications, less operative pain, improved cosmetic outcomes, and equivalent oncological results. These benefits drive the demand for nephrostomy devices, as they are commonly used in MIS procedures.

While the market has positive growth prospects, there are some challenges that may hinder its progress. Alternative procedures and the associated risks related to nephrostomy present potential obstacles to market growth. It is important to consider these factors when evaluating the overall market dynamics.

US Nephrostomy Device Market is poised to grow at a sustainable CAGR for the next forecast year.